Plain-English translation of NCT03655015 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building a living library of lung cancer cells taken directly from patients' tumors. These lab-grown cancer models will help doctors understand how each patient's unique cancer might respond to different treatments. The goal is to eventually use this information to personalize cancer care and improve treatment outcomes.
Every patient's lung cancer is different, and what works for one person may not work for another. By studying cancer cells from many different patients, researchers hope to learn which treatments work best for which types of lung cancer, and to develop better ways to predict how a patient's cancer will respond.
You likely qualify if…
You likely don't qualify if…
If you qualify, your tumor tissue will be collected during your surgery (which is already part of your standard care). Researchers will also ask you to complete a questionnaire about your background and health history. After that, your tumor sample will be used to grow cancer cells in the laboratory, and researchers will study how these cells behave and respond to different treatments. You will not receive any experimental medication or special treatment as part of this study.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
National Cancer Institute (NCI)
Enrollment target
~150 participants
Started
October 2018
Primary completion
December 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Josephine Taverna, MD
UT Health San Antonio M.D. Anderson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.